Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
Rhea-AI Summary
Teladoc Health (NYSE: TDOC) appointed Susan Salka to its board of directors, effective March 30, 2026. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. Ms. Salka will serve on the board’s audit and compensation committees.
Ms. Salka is the former president and CEO of AMN Healthcare, served 33 years there, led 26 acquisitions and helped grow revenue to over $5 billion. She currently serves on the board of Parexel and previously served on the boards of McKesson, Beckman Coulter and Playtex. She holds an MBA in Finance and a BA in Accounting and Economics.
Positive
- Adds experienced healthcare CEO with 33-year operational track record
- M&A experience: led 26 acquisitions at AMN Healthcare
- Contributed to revenue growth to over $5 billion at AMN
Negative
- Board turnover: retirements of Eric Evans and Thomas McKinley
News Market Reaction – TDOC
In the Mar 31 session, TDOC gained 6.03%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board’s audit and compensation committees.
“Susan brings a powerful combination of healthcare leadership and governance experience to the Board,” said Kenneth H. Paulus, non‑executive Chairman of the Teladoc Health board. “We will benefit from her insights on care delivery transformation as the company drives health outcomes at scale and creates durable value.”
During her 33-year tenure at AMN Healthcare, Ms. Salka was one of the driving forces behind the company's strategic and operational success. AMN pioneered the evolution of workforce solutions and made 26 acquisitions to meet the changing needs of clients, transforming the company and growing revenue to over
Ms. Salka currently serves on the board of Parexel International and previously served on the boards of McKesson Corporation, Beckman Coulter and Playtex Products. She holds an MBA in Finance from San Diego State University and a BA in Accounting and Economics from Chadron State College.
“Integrated, outcomes focused care is central to creating lasting value in healthcare,” said Salka. “Teladoc Health is an innovative leader and I look forward to contributing strategic and operational perspectives on the company’s next phase of growth.”
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612
Media:
Lou Serio
PR@teladochealth.com
202-569-9715
